Holen Sie sich die Stockscreener-App
26.02
6.94%
-1.94
Handel nachbörslich:
26.02
Schlusskurs vom Vortag:
$27.96
Offen:
$27.91
24-Stunden-Volumen:
933.28K
Relative Volume:
1.03
Marktkapitalisierung:
$1.59B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-197.68M
KGV:
-6.9202
EPS:
-3.76
Netto-Cashflow:
$-158.88M
1W Leistung:
-12.95%
1M Leistung:
+18.27%
6M Leistung:
+579.37%
1J Leistung:
+201.86%
1-Tages-Spanne:
$24.70
$28.23
1-Wochen-Bereich:
$24.70
$30.02
52-Wochen-Spanne:
$1.92
$31.18
Kodiak Sciences Inc Stock (KOD) Company Profile
Firmenname
Kodiak Sciences Inc
Sektor
Branche
Telefon
650-281-0850
Adresse
1250 PAGE MILL RD, PALO ALTO, CA
Vergleichen Sie KOD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
26.02 | 1.71B | 0 | -197.68M | -158.88M | -3.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-11 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-09-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-09-22 | Eingeleitet | Jefferies | Buy |
| 2025-08-14 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-12-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-05 | Eingeleitet | H.C. Wainwright | Neutral |
| 2023-12-11 | Fortgesetzt | Goldman | Sell |
| 2023-11-17 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-07-25 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-07-24 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-15 | Eingeleitet | CapitalOne | Overweight |
| 2022-08-02 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-02-24 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-03-12 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-01 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-02-17 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-01-25 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-11 | Eingeleitet | Citigroup | Neutral |
| 2020-11-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-11-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | Herabstufung | Goldman | Buy → Neutral |
| 2020-03-31 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-03 | Eingeleitet | Goldman | Buy |
| 2020-02-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-02-06 | Eingeleitet | SunTrust | Buy |
| 2020-01-08 | Eingeleitet | ROTH Capital | Buy |
| 2020-01-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-24 | Eingeleitet | JP Morgan | Overweight |
| 2019-10-15 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-10-29 | Eingeleitet | Barclays | Overweight |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Buy |
| 2018-10-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Kodiak Sciences Inc Aktie (KOD) Neueste Nachrichten
Kodiak Sciences Inc Stock Analysis and ForecastPrice Action Trading & Exceptional Capital Investment - earlytimes.in
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.8%Here's Why - MarketBeat
The Biggest IPO of the Year Prompts Huge Insider Buy - AOL.com
Investors Buy Big as Medline’s IPO Raises Over $6 Billion - cointurk finance
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 5.8%Here's Why - MarketBeat
Kodiak Sciences stock hits 52-week high at $29.52 By Investing.com - Investing.com Nigeria
Kodiak Sciences Stock Surge: An In-Depth Look - timothysykes.com
Kodiak Sciences (NASDAQ:KOD) Shares Up 6%Here's Why - MarketBeat
Kodiak Sciences stock hits 52-week high at $29.52 - Investing.com
Kodiak Sciences (NASDAQ:KOD) Hits New 52-Week HighWhat's Next? - MarketBeat
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025 - Finviz
Kodiak Sciences (NASDAQ:KOD) Shares Gap Up After Insider Buying Activity - MarketBeat
Kodiak Sciences Inc.(NasdaqGM: KOD) added to S&P Biotechnology Select Industry Index - marketscreener.com
Kodiak Sciences (KOD): Assessing Valuation After Its $160 Million Capital Raise for Late-Stage Pipeline - Sahm
Can Kodiak Sciences Inc. stock maintain operating marginsMarket Sentiment Summary & Stock Timing and Entry Methods - Улправда
Bros. Advisors Lp Baker Buys 2,608,696 Shares of Kodiak Sciences (NASDAQ:KOD) Stock - MarketBeat
Owner Baker Bros Advisors LP Buys 2,608,696 ($60M) Of Kodiak Sciences Inc [KOD] - TradingView — Track All Markets
Will Kodiak Sciences Inc. stock outperform value stocksWeekly Stock Analysis & Safe Entry Point Identification - bolumsonucanavari.com
Why Kodiak Sciences Inc. stock is in analyst buy zoneJuly 2025 Update & Free Safe Entry Trade Signal Reports - DonanımHaber
Is Kodiak Sciences Inc. stock safe for conservative investorsWeekly Investment Recap & High Accuracy Swing Trade Signals - Bölüm Sonu Canavarı
Kodiak Sciences closes $184 million public offering of common stock By Investing.com - Investing.com Nigeria
Kodiak Sciences closes $184 million public offering of common stock - Investing.com
Retina biotech raises $184M in stock sale as late-stage drug trials loom - Stock Titan
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares - marketscreener.com
Kodiak Sciences Raises Capital Through Completed Stock Offering - TipRanks
Kodiak Sciences (NASDAQ: KOD) completes $184M common stock sale - Stock Titan
Kodiak Sciences (NASDAQ:KOD) Stock Price Down 4.4%Here's Why - MarketBeat
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares - 富途牛牛
[424B5] Kodiak Sciences Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Is Kodiak Sciences Inc. (K27) stock included in top ETFsPortfolio Profit Report & Verified Technical Trade Signals - bollywoodhelpline.com
Kodiak Sciences (NASDAQ:KOD) Reaches New 12-Month HighShould You Buy? - MarketBeat
Kodiak Sciences stock hits 52-week high at 26.43 USD - Investing.com
Kodiak Sciences stock hits 52-week high at 26.43 USD By Investing.com - Investing.com Canada
Kodiak Sciences surges after boosted $160 mln equity raise - TradingView — Track All Markets
Kodiak Sciences Inc. (NASDAQ:KOD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Kodiak Sciences dips after boosted $160 mln equity raise - TradingView — Track All Markets
Kodiak Sciences’ Upsized Equity Raise Could Be A Game Changer For Kodiak Sciences (KOD) - Yahoo Finance
Retina drug developer sells nearly 7M new shares to raise $160M - Stock Titan
Kodiak Sciences prices upsized $160M stock offering at $23.00 per share - MSN
Kodiak Sciences (KOD) Expands Public Offering to Raise $160 Mill - GuruFocus
Kodiak Sciences Prices $160 Million Offering - marketscreener.com
Kodiak Sciences prices upsized public offering at $160 million - Investing.com
Kodiak Sciences prices upsized public offering at $160 million By Investing.com - Investing.com India
Kodiak Sciences prices upsized offering of 7 mln shares at $23.00 - marketscreener.com
Kodiak Sciences Prices Upsized Offering Of 7 Mln Shares At $23.00 - TradingView — Track All Markets
Kodiak Sciences Announces Pricing of Upsized Public Offering of Common Stock - marketscreener.com
Should Kodiak Sciences’ 6 Million-Share Offering Reshape How KOD Investors View Dilution Risk? - simplywall.st
Kodiak Sciences launches public offering of 6 mln shares - MSN
Kodiak Sciences (NASDAQ:KOD) Shares Gap DownHere's What Happened - MarketBeat
Kodiak Sciences announces public offering of 6 million shares By Investing.com - Investing.com Australia
Kodiak Sciences stock falls after announcing public offering - Investing.com India
Finanzdaten der Kodiak Sciences Inc-Aktie (KOD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):